حجم سوق الحقن داخل المفصل في أوروبا للتسللات العظمية المفصلية وتوقعاته (2021-2031)، والاتجاه، وتحليل فرص النمو: حسب النوع [الكولاجين من النوع 1 (البوليمر، والمحلل، والأتيلوكولاجين) وحمض الهيالورونيك]، والمستخدم النهائي (المستشفيات، والعيادات العظمية، وغيرها)، والبلد
الحقن داخل المفصل لهشاشة العظام هو إجراء طبي يتم فيه حقن الدواء مباشرة في المفصل المصاب بهشاشة العظام. ويهدف هذا النهج إلى تقليل الألم وتحسين وظيفة المفصل. إن زيادة الوعي بين المتخصصين في الرعاية الصحية والمرضى فيما يتعلق بفوائد هذه الحقن، إلى جانب زيادة الاستثمار في البنية التحتية للرعاية الصحية والابتكار، يسهل زيادة الوصول إلى هذه العلاجات. إن الانتشار المتزايد لهشاشة العظام والتقدم في تقنيات الحقن من العوامل الجديرة بالملاحظة التي تساهم في توسيع حجم سوق الحقن داخل المفصل في أوروبا للتسللات العظمية المفصلية. ومع ذلك، فإن الآثار الجانبية المرتبطة بالحقن داخل المفصل تعيق نمو سوق الحقن داخل المفصل في أوروبا للتسللات العظمية المفصلية.
تعتبر الحقن داخل المفصل من بين المجالات المبتكرة والناشئة لعلاج التسللات العظمية المفصلية. يشارك المصنعون في تجارب سريرية مختلفة لضمان سلامة وفعالية وموثوقية الأدوية المبتكرة. على سبيل المثال، في مايو 2024، بدأت الشركة السويدية، سينارترو، في جمع رأس مال يتراوح بين 3.73 و7.36 مليون دولار أمريكي لإجراء دراسة سريرية لمرشح هشاشة العظام SYN321. وهي في المرحلة النهائية لتأمين منحة من الاتحاد الأوروبي بقيمة 2.78 مليون دولار أمريكي. بالإضافة إلى ذلك، في أبريل 2023، حصلت الشركة على موافقة من وكالة المنتجات الطبية السويدية وهيئة المراجعة الأخلاقية السويدية لبدء المرحلة 1/2a أول دراسة سريرية على البشر للمرشح التجريبي للدواء SYN321. كما تجري جهات أخرى في السوق في المناطق تجارب سريرية للحقن داخل المفصل، مما قد يؤدي إلى تطوير منتجات مبتكرة. على سبيل المثال، في أغسطس 2022، قامت شركة Grünenthal الألمانية بتسجيل أول مريض في برنامجها السريري العالمي للمرحلة الثالثة للريزينيفيراتوكسين (RTX). أجرت Grünenthal ثلاث تجارب في حوالي 200 موقع في جميع أنحاء أوروبا والولايات المتحدة وأمريكا اللاتينية وجنوب إفريقيا واليابان للتحقيق في سلامة وفعالية الحقن داخل المفصل للريزينيفيراتوكسين لدى البالغين. تركز النتائج الملحوظة في التجارب بشكل أساسي على تحسن الوظيفة الجسدية ودرجة الألم في مؤشر هشاشة العظام في جامعتي غرب أونتاريو وماكماستر (WOMAC) من الأساس إلى 52 أسبوعًا. عند الانتهاء، يهدف برنامج المرحلة الثالثة إلى توفير الموافقة على تسويق RTX في أوروبا والولايات المتحدة واليابان. تعتزم الشركة تقديم طلب دواء جديد في عام 2024، مما يشير إلى دخول RTX المحتمل إلى السوق في عام 2025. لذلك، من المتوقع أن يعزز العدد المتزايد من التجارب السريرية تطوير المنتجات المبتكرة في المنطقة، مما سيساهم بدوره في نمو سوق الحقن داخل المفصل في أوروبا للتسلل العظمي المفصلي في السنوات القادمة.
رؤى قائمة على النوع
بناءً على النوع، يتم تقسيم سوق الحقن داخل المفصل في أوروبا للتسلل العظمي المفصلي إلى الكولاجين من النوع 1 وحمض الهيالورونيك. احتل قطاع حمض الهيالورونيك أكبر حصة في سوق الحقن داخل المفصل في أوروبا للتسلل العظمي المفصلي في عام 2023 تُستخدم حقن حمض الهيالورونيك لعلاج آلام الركبة لدى المرضى الذين لم يستجيبوا لخيارات العلاج الأخرى. أدت التطورات الأخيرة في علاج حقن حمض الهيالورونيك إلى توسيع مسار النمو بشكل كبير. ومن المتوقع أن يدعم التركيز القوي على تطوير وتقديم منتجات جديدة في السوق نمو القطاع، وبالتالي المساهمة في نمو السوق.
تعد مراكز السيطرة على الأمراض والوقاية منها، ومنظمة الصحة العالمية، والمركز الوطني لمعلومات التكنولوجيا الحيوية من بين المصادر الأولية والثانوية التي تمت الإشارة إليها أثناء إعداد تقرير سوق الحقن داخل المفصل في أوروبا للتسللات العظمية المفصلية.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Information on why collagen injections are better than HA injections
4.4 Pricing Analysis
5. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Key Market Dynamics
5.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Osteoarthritis
5.2.2 Advancements in Injection Techniques
5.3 Market Restraints
5.3.1 Side Effects Associated with Intra-Articular Injections
5.4 Market Opportunities
5.4.1 Strategic Initiatives in Intra-Articular Injection for Osteoarticular Infiltrations
5.5 Future Trends
5.5.1 Increasing Number of Clinical Trials
5.6 Impact of Drivers and Restraints:
6. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Analysis
6.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue (US$ Million), 2021–2031
6.2 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Forecast and Analysis
7. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Analysis – by Type
7.1 Type 1 Collagen
7.1.1 Overview
7.1.2 Type 1 Collagen: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Hyaluronic Acid
7.2.1 Overview
7.2.2 Hyaluronic Acid: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Analysis – by End User
8.1 Hospitals
8.1.1 Overview
8.1.2 Hospitals: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Orthopedic Clinics
8.2.1 Overview
8.2.2 Orthopedic Clinics: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Others
8.3.1 Overview
8.3.2 Others: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
9. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Country Analysis
9.1 Europe
9.1.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Countries
9.1.2 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue and Forecast and Analysis – by Country
9.1.2.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue and Forecast and Analysis – by Country
9.1.2.2 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.2.1 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
9.1.2.2.2 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
9.1.2.2.3 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
9.1.2.3 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.3.1 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
9.1.2.3.2 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
9.1.2.3.3 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
9.1.2.4 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.4.1 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
9.1.2.4.2 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
9.1.2.4.3 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
9.1.2.5 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.5.1 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
9.1.2.5.2 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
9.1.2.5.3 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
9.1.2.6 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.6.1 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
9.1.2.6.2 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
9.1.2.6.3 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
9.1.2.7 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.7.1 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
9.1.2.7.2 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
9.1.2.7.3 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
9.1.2.8 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.8.1 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
9.1.2.8.2 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
9.1.2.8.3 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
10. Industry Landscape
10.1 Overview
10.2 Growth Strategies in Intra-Articular Injection For Osteoarticular Infiltrations Market
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Inorganic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Bioventus Inc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 SEIKAGAKU CORPORATION
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Maxigen Biotech Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 ?stem Medical Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Sanofi SA
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Ferring Pharmaceuticals
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Fidia Pharma USA Inc.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Biotech Healthcare Group
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Bioteck S.p.A.
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 I+MED
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
List of Tables
Table 1. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Segmentation
Table 2. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Table 3. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 4. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen
Table 5. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 6. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Country
Table 7. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 8. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen
Table 9. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 10. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 11. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen
Table 12. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 13. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 14. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen
Table 15. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 16. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 17. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen
Table 18. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 19. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 20. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen
Table 21. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 22. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 23. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen
Table 24. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 25. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 26. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by Type 1 Collagen
Table 27. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 28. Recent Organic Growth Strategies in Intra-Articular Injection For Osteoarticular Infiltrations Market
Table 29. Recent Inorganic Growth Strategies in the Intra-Articular Injection For Osteoarticular Infiltrations Market
Table 30. Glossary of Terms, Europe Intra-Articular Injection For Osteoarticular Infiltrations Market
List of Figures
Figure 1. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue (US$ Million), 2021–2031
Figure 5. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Share (%) – by Type, 2023 and 2031
Figure 6. Type 1 Collagen: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Hyaluronic Acid: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Share (%) – by End User, 2023 and 2031
Figure 9. Hospitals: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Orthopedic Clinics: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Others: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 13. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Growth Strategies in Intra-Articular Injection For Osteoarticular Infiltrations Market
- Bioventus Inc.
- SEIKAGAKU CORPORATION
- Maxigen Biotech Inc.
- ?stem Medical Inc.
- Sanofi SA
- Ferring Pharmaceuticals
- Fidia Pharma USA Inc.
- Biotech Healthcare Group
- Bioteck S.p.A.
- I+MED.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe intra-articular injection for osteoarticular infiltrations market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe intra-articular injection for osteoarticular infiltrations market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.